Acetate

Generic Name: Acetate

Drug Type: Small Molecule

Chemical Formula: C_₂H_₃O_₂

CAS Number: 71-50-1

Unique Ingredient Identifier: 569DQM74SC

Clinical Trials

Effects of Acetate and Alcohol on Brain Function

Not Applicable

Completed

Conditions: Brain Function
Cerebral Blood Flow

Interventions: Drug: alcohol
Drug: acetate

First Posted Date: 2015-09-04

Last Posted Date: 2021-06-25

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 24

Registration Number: NCT02542150

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

Phase 2

Completed

Conditions: Tuberculosis
HIV-1 Infection

Interventions: Drug: Depot medroxyprogesterone acetate

First Posted Date: 2015-04-09

Last Posted Date: 2019-07-01

Lead Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Target Recruit Count: 62

Registration Number: NCT02412436

Locations: 🇧🇼
Gaborone Prevention/Treatment Trials CRS (12701), Gaborone, Botswana
🇰🇪
Kenya Medical Research Institute/Center for Disease Control (KEMRI/CDC) CRS (31460), Kisumu, Kenya
🇿🇦
Durban Adult HIV CRS (11201), Durban, South Africa

and more 2 locations

Balanced Salt Solution VS. Normal Saline Solution in Septic Shock

Phase 3

Completed

Conditions: Shock, Septic
Sepsis

Interventions: Drug: Ringer acetate
Drug: Normal saline

First Posted Date: 2015-01-13

Last Posted Date: 2017-04-26

Lead Sponsor: Ramathibodi Hospital

Target Recruit Count: 60

Registration Number: NCT02336620

Locations: 🇹🇭
Department of Pediatric,Ramathibodi Hospital, Bangkok, Thailand

The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy

Phase 2

Conditions: Complex Atypical Endometrial Hyperplasia
Grade 1 Endometrial Endometrioid Adenocarcinoma
Grade 2 Endometrial Endometrioid Adenocarcinoma

Interventions: Drug: Depot medroxyprogesterone acetate
Other: Placebo

First Posted Date: 2015-01-09

Last Posted Date: 2016-09-20

Lead Sponsor: Women and Infants Hospital of Rhode Island

Target Recruit Count: 76

Registration Number: NCT02335203

Locations: 🇺🇸
Women and Infants Hospital, Program in Women's Oncology, Providence, Rhode Island, United States

Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: IM Saline Placebo (0.25 ml)
Drug: IM Estradiol valerate (2.5 mg)
Drug: IM Saline Placebo (0.5 ml)
Drug: IM Estradiol valerate (5.0 mg)
Drug: Oral Placebo
Drug: Oral Micronized Progesterone
Drug: Ghrelin (0.3 ug/kg)
Drug: Medroxyprogesterone - Acetate

First Posted Date: 2014-10-23

Last Posted Date: 2018-03-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 47

Registration Number: NCT02272647

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected Women

Phase 4

Completed

Conditions: Contraception
HIV

Interventions: Drug: Depo-Medroxyprogesterone Acetate
Drug: Progestin Contraceptive (Jadelle)

First Posted Date: 2014-04-04

Last Posted Date: 2018-03-19

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 131

Registration Number: NCT02103660

Locations: 🇲🇼
UNC-Project Lilongwe, Lilongwe, Malawi

Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of Endometriomas

Phase 1

Completed

Conditions: Endometriosis

Interventions: Drug: depot medroxyprogesterone acetate

First Posted Date: 2013-02-15

Last Posted Date: 2013-09-09

Lead Sponsor: Mahidol University

Target Recruit Count: 40

Registration Number: NCT01791413

Locations: 🇹🇭
Department of Obstetrics and Gynecology, Ratchathewi, Bangkok, Thailand

The Effect of Administering a Small Dose of Glucose During Cesarean Section

Not Applicable

Conditions: Cesarean Section

Interventions: Drug: administer acetate Ringer's solution
Drug: acetate Ringer's solution containing no glucose
Drug: acetate Ringer's solution containing 1% glucose

First Posted Date: 2012-10-15

Last Posted Date: 2012-10-15

Lead Sponsor: Nagoya City University

Target Recruit Count: 40

Registration Number: NCT01706341

Locations: 🇯🇵
Departiment of Anesthesiology, Nagoya City University Hospital, Nagoya, Japan

Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity

Not Applicable

Conditions: Infertility

Interventions: Drug: Luprolide Acetate
Drug: Cetrorelix

First Posted Date: 2012-05-10

Last Posted Date: 2012-05-25

Lead Sponsor: Southern Cross Fertility Centre

Target Recruit Count: 300

Registration Number: NCT01595334

Locations: 🇮🇳
Disha Fertility & Surgical Hospital, Indore, Madhya Pradesh, India
🇮🇳
Southern Cross Fertility Center, Mumbai, Maharashtra, India
🇮🇳
Sat Kaival Hospital Pvt. Ltd., Anand, Gujarat, India

C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma

Phase 2

Completed

Conditions: Prostate Cancer
Prostate Adenocarcinoma

Interventions: Drug: C11-Sodium Acetate

First Posted Date: 2012-02-09

Last Posted Date: 2019-03-07

Lead Sponsor: Phoenix Molecular Imaging

Target Recruit Count: 300

Registration Number: NCT01530269

Locations: 🇺🇸
Phoenix Molecular Imaging, Phoenix, Arizona, United States

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy